Trump’s 100% drug tariff hits pharma shares in Europe and Asia
NegativeFinancial Markets
Trump's recent decision to impose a 100% tariff on pharmaceuticals has sent shockwaves through the markets, particularly affecting shares in Europe and Asia. This move not only raises concerns about the future of drug pricing and availability but also signals a potential escalation in trade tensions. Investors are wary as the pharmaceutical sector grapples with the implications of such tariffs, which could lead to increased costs for consumers and reduced access to essential medications.
— Curated by the World Pulse Now AI Editorial System